CEO of Ribbon Biolabs 

Jodi Barrientos, CEO of Ribbon Biolabs in Santa Clara, California, boasts a rich 17-year career in biotechnology. With expertise in commercial excellence and digital transformation, she previously held key roles at Agilent Technologies, Qiagen, and Roche Diagnostics. Jodi, a former bench scientist, holds a BS in Biology from Purdue University Fort Wayne and is dedicated to mentoring in STEM while balancing her career with motherhood. Passionate about innovation, she leads Ribbon Biolabs, driving growth and addressing dynamic market needs in biotechnology.

CCO of Maravai Life Science 

Becky Buzzeo, Senior VP and CCO at Maravai Life Sciences in Boston, boasts a seasoned sales leadership background. Skilled in strategic planning, negotiation, and team development, she focuses on managing key customer relationships and enabling drug therapies and diagnostics. Previously at Thermo Fisher Scientific, she led CDMO services for advanced therapies. With a BS in Biology from Slippery Rock University, Becky's career includes roles at industry giants like Novartis and Bio-Rad Laboratories, driving global commercial operations and business development.

CEO & Chief Regulatory Consultant of Cerneos Group, LLC

Richard Tharin is the CEO & Chief Regulatory Consultant of Cerneos Group, LLC.  Cerneos provides comprehensive consulting services with expertise in regulatory affairs, life sciences, product and business development strategies. We help in every step throughout the bench to body continuum. Whether clients are a first-time entrepreneur or an established life science company, our mission is to help clients achieve their goals by providing end-to-end solutions for life science innovators

CCO of Dare BioScience 

John Fair, Chief Commercial Officer at Daré Bioscience, Inc. in San Diego, oversees global commercial strategy, business development, and alliances, driving growth and partnerships with industry leaders like Bayer and the Bill & Melinda Gates Foundation. With over 5 years at Daré, he shapes diverse brand portfolios and technology platforms, optimizing performance and delivering value to patients. His extensive background includes leadership roles and profitable scaling of multibillion-dollar product portfolios in areas such as oncology and women's health. John holds a Masters in Medical Ethics & Health Policy from the University of Pennsylvania, a Certificate in Mergers & Acquisitions from Stanford University, and a BA from Rider University.

Partner and Owner of Thorelli & Associates, 

Thomas Thorelli is the Partner and Owner of Thorelli & Associates, based in the Greater Chicago Area. With 38 years of experience, he specializes in providing comprehensive legal assistance to small and medium-sized foreign companies navigating the intricacies of doing business in the U.S. Thorelli & Associates focuses on minimizing legal risks through proactive measures, offering expertise in strategic planning, intellectual property protection, licensing, contract negotiations, product distribution, corporate structuring, organizational matters, employment issues, business-related immigration and visas, dispute resolution, and product liability preventive management. Thomas holds a JD-MBA from Washington University in St. Louis (1979), and a Bachelor's degree in Economics from Indiana University Bloomington (1975). He also studied at the University of Strasbourg in 1973-1974.

Co-Founder of Go To Market Global (GTM Global),

Mark Stimpfig, Co-Founder of Go To Market Global (GTM Global) since 2015, spearheads a pioneering ecosystem in London supporting tech and digital scale-up companies worldwide. With a robust program of events and consultancy services, GTM Global strategically collaborates with public and private sector partners, fostering connections for international expansion. Mark's leadership has cultivated a vibrant community of 6,000+ UK tech scale-ups, while also serving as a Trustee for St Johns Church Notting Hill, contributing to community engagement. His diverse career includes roles at Greater Phoenix Economic Council and Lucid Fusion, Inc., complemented by a Master's in History from the University of Cambridge.

Chief Business Officer at Kite Therapeutics

Gurpreet Ratra, Chief Business Officer at Kite Therapeutics in the San Francisco Bay Area, leverages extensive expertise in life sciences. With a background spanning science, finance, and business in biotechnology, he evaluates novel therapeutics for various diseases. Currently focusing on genetic medicines for muscle diseases, Gurpreet previously held leadership roles at Skyline Therapeutics and Spark Therapeutics, among others, and holds an MBA from UC Berkeley and a Ph.D. in Biochemical Toxicology from St. Bartholomew's Medical School, London.